Don’t perform routine measurement of C-peptide in diabetes patients.
It is not necessary to dose hematic C-peptide for the diagnosis of type 1 and type 2 diabetes . Measurement of the response by C-peptide to glucagon or to mixed meals can help in rare cases in which it is difficult to differentiate the diagnosis between the two types...
Don’t prescribe routine glucose self-monitoring to Type 2 diabetes patients who are being treated with drugs that do not cause hypoglycemia.
In patients with type 2 diabetes being treated with drugs which do not cause hypoglycemia, once the glycemic objective has been reached and the results of self- monitoring become fairly predictable, daily monitoring of the glycemia does not add information for...
Prescribe fecal occult blood test (FOBT) only for screening of colorectal cancer.
FOBT is a screening test that should only to be used for asymptomatic patients that are in the risky area outlined by the relevant national or regional programs. It’s not a diagnostic test and as such should not be performed for patients that show signs and symptoms...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments